वैक्सीन पर पूरी तरह भरोसा नहीं करते लोग: लांसेट

वैक्सीन पर लोग कितना भरोसा करते हैं, इस बारे में लांसेट ने 149 देशों के 284,381 व्यक्तियों लोगों के बीच एक सर्वेक्षण किया

कोरोना वैक्सीन अपडेट: कोविशील्ड के तीसरे चरण के चिकित्सीय परीक्षण के लिए पूरा हुआ नामांकन

भारत में विकसित किए जा रही वैक्सीन में, कोविशील्ड मानव परीक्षण के उन्नत चरण में है

कोविड-19 वैक्सीन का सबसे बड़ा उत्पादक बन सकता है भारत: हॉटेज

ग्लोबल वैक्सीनेशन में भारत की भूमिका, इसकी चुनौतियां, वैक्सीन विरोधी अभियान और इस पर हो रही राजनीति पर हॉटेज ने डाउन टू अर्थ से ...

Why the Oxford AstraZeneca vaccine is now a global game changer

There were no cases of severe COVID-19 in those who received the vaccine. And it seems to generate a protective immune response in older people

कोरोना वैक्सीन अपडेट: रूस से भारत आएंगी 10 करोड़ वैक्सीन

कोविड-19 वैक्सीन स्पुतनिक-5 को लेकर रूस की एजेंसी आरडीआईएफ और डॉ रेड्डीज लेबोरेट्रेजी के बीच एक समझौता हुआ है

The 'vaccinegate' of Italy

A study in Italy has found major contaminants in vaccines that are used the world over

India develops first indigenous vaccine to treat bloody dysentry

Shigellosis is recognised as a disease mainly affecting Asian and African nations

Vaccine hesitancy on the rise across the globe, reveals cross-country survey

India bucks the trend; Afghanistan, Indonesia, Pakistan, the Philippines, South Korea major concerns

Did Punjab introduce cancer vaccine based on faulty research by PGI Chandigarh?

Claims made by the professors at PGIMER have been challenged by a member of the National Technical Advisory Group on Immunisation

COVID-19: Extensive research underway; how much will it help?

As many as 42 vaccines were in preclinical stage and two vaccines in Phase I clinical trials as of March 20, according to WHO  

Race to procure COVID-19 vaccine doses: Where do countries stand?

India has confirmed the maximum number of doses at 1.6 billion

WHO adopts plan to make vaccines cheaper and more accessible

Calls for transparency around vaccine pricing and procurement

COVID-19 vaccine development: It’s a relay race

The reason trials are taking shorter time is because developers are taking more risks

Roti, kapda, makaan... and vaccine: Can it sway elections

With potential COVID-19 vaccines equalling cheap foodgrains’ power as a poll promise, can vaccine sub-nationalism be far behind

Simply put: Let’s plant a COVID-19 vaccine

Low vaccine coverage could be behind measles outbreaks: WHO

The world saw 300 per cent more cases in the first three months of 2019 compared to last year

कोरोना वैक्सीन अपडेट: 13 फीसदी धनी देशों ने खरीदी आधी से ज्यादा वैक्सीन खुराक: ऑक्सफैम

ऑक्सफैम ने अपनी एक रिपोर्ट में कहा है कि दुनिया की 61 फीसदी आबादी तक 2022 के अंत तक भी वैक्सीन नहीं पहुंच पाएगी

Vaccine-derived polio virus found 50 times in India in six years

The vaccine-derived polio virus is a rare strain of polio virus that has genetically mutated from the strain contained in the oral polio vaccine

India should not prefer Russian COVID-19 vaccine over own: Vaccinologist Peter Hotez

India has a golden chance to emerge as a superpower; vaccine dissemination would be a paramount challenge, Hotez says in an …

Simply Put: Vaccine vs COVID-19

How ‘vaccine nationalism’ could block vulnerable populations’ access to COVID-19 vaccines

Vaccine nationalism also runs against the fundamental principles of vaccine development and global public health

Human trials of Ebola vaccines start in Liberia

Trials are being done at an undisclosed location under tight security

Polio eradication: we are not there yet

On the occasion of World Polio Day, we take a look at the challenges that three countries are facing in eradicating this debilitating disease

COVID-19: Phase 3 of vaccine developed by Chinese researchers underway, says Lancet

The Ad5-vectored COVID-19 vaccine tested on people above 55 years of age, is considered a step up from another vaccine being developed by the UK

Simply put: The (side) effects of COVID-19 vaccine